Literature DB >> 6364332

A dose-duration study of metronidazole for the treatment of nonspecific vaginosis.

D A Eschenbach, C W Critchlow, H Watkins, K Smith, C A Spiegel, K C Chen, K K Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6364332

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN： 0300-8878


× No keyword cloud information.
  9 in total

Review 1.  Bacterial vaginosis.

Authors:  C A Spiegel
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis.

Authors:  R L Cook; V Redondo-Lopez; C Schmitt; C Meriwether; J D Sobel
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Diagnosis of Gardnerella vaginalis infection by an enzyme-linked immunosorbent assay.

Authors:  M A Bratos; A Orduña; J Medina; R O de Lejarazu; A Rodríguez-Torres
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  Pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis.

Authors:  Xin Wang; Tatiana N Nanovskaya; Ying Zhan; Susan M Abdel-Rahman; Marlo Jasek; Gary D V Hankins; Mahmoud S Ahmed
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07-07

Review 5.  Antibiotic treatment for the sexual partners of women with bacterial vaginosis.

Authors:  Jairo Amaya-Guio; David Andres Viveros-Carreño; Eloisa Mercedes Sierra-Barrios; Mercy Yolima Martinez-Velasquez; Carlos F Grillo-Ardila
Journal:  Cochrane Database Syst Rev       Date:  2016-10-01

6.  The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicentre, double blind, placebo controlled trial. B V Investigators Group.

Authors:  I H Ahmed-Jushuf; M Shahmanesh; O P Arya
Journal:  Genitourin Med       Date:  1995-08

7.  Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

Authors:  R Scott McClelland; Barbra A Richardson; Wisal M Hassan; Vrasha Chohan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Walter Jaoko; Jeckoniah O Ndinya-Achola; Jared M Baeten; Ann E Kurth; King K Holmes
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

8.  A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women.

Authors:  R Scott McClelland; Barbra A Richardson; Susan M Graham; Linnet N Masese; Ruth Gitau; Ludo Lavreys; Kishorchandra Mandaliya; Walter Jaoko; Jared M Baeten; Jeckoniah O Ndinya-Achola
Journal:  Sex Transm Dis       Date:  2008-06       Impact factor: 2.830

9.  Should male consorts of women with bacterial vaginosis be treated?

Authors:  H Moi; R Erkkola; F Jerve; G Nelleman; B Bymose; K Alaksen; E Tornqvist
Journal:  Genitourin Med       Date:  1989-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.